We are proud to announce that EnviroZyme® has entered into a binding agreement to acquire certain wastewater business assets from Novozymes®* A/S. Novozymes is the world leader in biological solutions and the largest provider of enzyme and microbial technologies to improve industrial performance while preserving the planet's resources and helping build better lives.
EnviroZyme is a top provider of bacteria-based treatment solutions for a variety of environmental, water, and waste treatment applications, complete with downstream packaging solutions and fermentation capabilities in an FDA-registered, state-of-the-art manufacturing facility. The integration of Novozymes wastewater business unit will transform EnviroZyme into the world’s leading provider of bioaugmented solutions for water resource recovery.
“Novozymes has an outstanding portfolio of wastewater customers and product solutions that complements the existing EnviroZyme business and facilitates access into new markets globally,” said Toby Jercovich, Chief Financial Officer. “This acquisition will allow us to immediately fulfill a strategic growth initiative and provides a significant opportunity for long-term, accretive earnings.”
With each party’s deep geographical reach and dominant positions in key regions, the combined business will capture momentous market share in the rapidly expanding water and environmental technologies space. The transaction will also broaden the products, services, and expertise offered by EnviroZyme, serving to further strengthen and differentiate their overall wastewater platform.
Subject to customary closing conditions and adjustments, the acquisition will be fully funded at the targeted close date during the first quarter of 2023. EnviroZyme representatives will be debuting and discussing the evolving business at the upcoming WEFTEC 2022 Conference, the world's largest annual water quality event, from October 8 through October 12 in New Orleans, LA.
*Novozymes is a registered trademark of Novozymes A/S